MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1,019 Cr | ₹89 Cr | ₹48 Cr | ₹83 Cr | ₹35 Cr |
What is the latest Contingent Liabilities ratio of MANKIND PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1,019 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹83 Cr |
| Mar2021 | ₹35 Cr |
How is Contingent Liabilities of MANKIND PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,019 Cr | 1,045.33 | |
| Mar2024 | ₹89 Cr | 85.77 | |
| Mar2023 | ₹48 Cr | -41.97 | |
| Mar2022 | ₹83 Cr | 137.32 | |
| Mar2021 | ₹35 Cr | - | |
Compare Contingent Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,551.0 Cr | 1.7% | 8.3% | 9.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.7% |
8.3% |
9.4% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses